62496-43-9Relevant academic research and scientific papers
INHIBITORS OF CD40-CD154 BINDING
-
Paragraph 00386; 00392, (2020/10/21)
Disclosed herein are compounds including pharmaceutically acceptable salts, esters, prodrugs, hydrates and tautomers thereof which modulate the interactions of CD-40-CD40L. The compounds are useful for treating, ameliorating or preventing an autoimmune disease, inflammatory disease, or other immune-related disease in a patient in need of treatment.
